These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23609189)

  • 1. The prostate cancer-up-regulated Myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor.
    Jiao L; Li Y; Shen D; Xu C; Wang L; Huang G; Chen L; Yang Y; Yang C; Yu Y; Sun Y
    Med Oncol; 2013; 30(2):570. PubMed ID: 23609189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
    Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells.
    He J; Lan X; Duan HL; Luo H; Zhou XD
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
    Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
    Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression.
    Yang W; Wang K; Ma J; Hui K; Lv W; Ma Z; Huan M; Luo L; Wang X; Li L; Chen Y
    Arch Med Res; 2021 Feb; 52(2):174-181. PubMed ID: 33059953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
    Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
    Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
    Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
    EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM
    J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
    Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
    Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.
    Ferreira LB; Palumbo A; de Mello KD; Sternberg C; Caetano MS; de Oliveira FL; Neves AF; Nasciutti LE; Goulart LR; Gimba ER
    BMC Cancer; 2012 Nov; 12():507. PubMed ID: 23130941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
    Wang T; Abou-Ouf H; Hegazy SA; Alshalalfa M; Stoletov K; Lewis J; Donnelly B; Bismar TA
    J Mol Med (Berl); 2016 Dec; 94(12):1411-1422. PubMed ID: 27534968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIP30 is associated with progression and metastasis of prostate cancer.
    Zhang H; Zhang Y; Duan HO; Kirley SD; Lin SX; McDougal WS; Xiao H; Wu CL
    Int J Cancer; 2008 Aug; 123(4):810-6. PubMed ID: 18528861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
    Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
    Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer.
    Zhou Y; Ou L; Xu J; Yuan H; Luo J; Shi B; Li X; Yang S; Wang Y
    Cell Death Dis; 2021 Jul; 12(7):668. PubMed ID: 34215720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.